Adaptation of Linehan's Biosocial Model to Emotional Dysregulation in Autism Spectrum Disorder (DE-TSA)

March 12, 2024 updated by: University Hospital, Strasbourg, France

Proposal for an Adaptation of Linehan's Biosocial Model to Emotional Dysregulation in Autism Spectrum Disorder: Narrative Review of the Literature and Clinical Case

Linehan's biosocial model conceptualizes the factors at play in the development of emotional dysregulation (ED), that is, difficulty regulating one's emotions, in borderline personality disorder (BPD). The model explains ED as the result of the interaction between the person's biological emotional vulnerability and their exposure to early invalidating experiences from those around them. Recently, ED has been shown to be prevalent in autism spectrum disorder (ASD). The objective of the study is to propose an adaptation of Linehan's model to the specificities of ASD to conceptualize the factors contributing to ED in the context of this disorder. To do this, the investigators will carry out a narrative literature review, as well as an illustrative case conceptualization based on the proposed model.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Strasbourg, France, 67091
        • Service de Psychiatrie - CHU de Strasbourg - France

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult subjects (≥18 years old) Having been diagnosed with ASD without intellectual disability

Description

Inclusion Criteria:

  • Adult subjects (≥18 years old)
  • Having been diagnosed with ASD without intellectual disability
  • Presenting severe ED with self-harming behaviors and/or suicidal behaviors

Exclusion Criteria:

- Subjects not meeting the study eligibility criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adaptation of Linehan's biosocial model to emotional dysregulation in autism spectrum disorder
Time Frame: The bibliography research will cover the period from 2015 to 2021.
This study is based on a narrative literature review, and will propose an illustrative case conceptualization based on Linehan's biosocial model.
The bibliography research will cover the period from 2015 to 2021.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2023

Primary Completion (Actual)

May 21, 2023

Study Completion (Actual)

May 21, 2023

Study Registration Dates

First Submitted

December 14, 2023

First Submitted That Met QC Criteria

January 9, 2024

First Posted (Actual)

January 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 8726 (Other Grant/Funding Number: Mead Johnson Nutrition)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe